These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1652224)

  • 61. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical evaluation of postoperative adjuvant arterial infusion chemotherapy in resected hepatoma patients].
    Nakashima K; Aramaki M; Yoshida T; Kim YI; Kitano S; Kobayashi M; Suzuki K; Aikawa H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1481-4. PubMed ID: 8396901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
    Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
    Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Long-term outcome of advanced hepatocellular carcinoma that received transarterial hepatic chemotherapy].
    Masutani S; Shimizu J; Tatsuta M; Masuda F; Imamura H; Ishida H; Furukawa H; Tomotsu K; Yura M; Obana T; Kitamura S; Saeki N; Inoue Y; Takamura M; Ohnishi H
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1579-82. PubMed ID: 14619468
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Complete response to treatment with low-dose FP therapy in a patient with stage IVB primary hepatocellular carcinoma with multiple lung and bone metastases].
    Fukuda Y; Fujio N; Takatori H; Tsukazaki T; Terakura M; Mayumi K; Koyama I; Tsukazaki Y; Osugi H
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):107-11. PubMed ID: 14750333
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Usefulness of hepatic arterial infusion chemotherapy using lecithin-added lipiodol emulsion in hepatocellular carcinoma].
    Kobayashi S; Koizumi S; Katagiri S; Ariizumi S; Takahashi Y; Otsubo T; Takasaki K; Yamamoto M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1433-7. PubMed ID: 17876141
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Successful treatment of postoperative multiple hepatic recurrence with hepatic arterial infusion of cisplatin and degrable starch microspheres].
    Murakami M; Tono T; Imazato M; Takemoto H; Asaoka T; Okada K; Kanoh T; Iwazawa T; Ohnishi T; Nakano Y; Yano H; Kinuta M; Okamura J; Monden T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1665-8. PubMed ID: 14619489
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma].
    Yodono H; Tarusawa K; Kanehira J; Fukuda E; Ikami I; Sakaki T; Kamata K; Sasaki D; Sasaki M
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3476-82. PubMed ID: 3024580
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical utility of transarterial infusion chemotherapy using cisplatin-lipiodol emulsion for unresectable hepatocellular carcinoma.
    Beppu T; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Ogura S; Kasai C; Kusagawa S; Nojiri K; Yoneda M; Fuke H; Yamamoto N; Takei Y; Fujimori M; Hasegawa T; Yamanaka T; Uraki J; Kashima M; Takaki H; Nakatsuka A; Yamakado K; Takeda K
    Anticancer Res; 2012 Nov; 32(11):4923-30. PubMed ID: 23155261
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effect of lipiodol-cisplatinum arterial infusion chemotherapy on cellular immunity].
    Ohsumi M; Koitabashi H; Nagamachi Y; Iijima T
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):327-31. PubMed ID: 1311914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma.
    Ichida T; Kato M; Hayakawa A; Ito S; Mori S; Sato T; Sugitani S; Sato H; Watanabe M; Asakura H
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S74-8. PubMed ID: 8137488
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study.
    Ichida T; Kato M; Hayakawa A; Watanabe M; Igarashi K; Hata K; Doya Y; Miura M; Sato H; Asakura H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S51-4. PubMed ID: 1281045
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (II)--A clinical study].
    Shibata J; Kimura S; Chikazawa H; Miyase S; Sakai M; Morishita T; Fujiyama S; Sato T; Fukushima S; Kishimoto S
    Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2750-9. PubMed ID: 2854838
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepatocellular carcinoma.
    Tamura Y; Ikeda O; Nakasone Y; Iryo Y; Yamashita Y
    Acta Radiol; 2010 May; 51(4):383-8. PubMed ID: 20192896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Anticancer effect and side effect of arterial chemoembolization using cis-diamine-dichloroplatinum (II)/4-0-tetrahydropyranyl-adriamycin-lipiodol (CTL) suspension on hepatocellular carcinoma].
    Takeshita T; Inoue H; Miyazono N; Hori A; Harada O; Satake M; Kanetsuki I; Nishida H; Sagara K; Shinmaki H
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1867-72. PubMed ID: 1381572
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Intra-arterial chemotherapy with cisplatin-phosphatidylcholine-lipiodol suspension (CPLS) for invasive bladder cancer].
    Yamashita S; Kanetake H; Saito Y; Nakashima M; Ogasawara M; Ichikawa M; Isomoto I; Matsunaga N
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1087-9. PubMed ID: 1320848
    [No Abstract]   [Full Text] [Related]  

  • 78. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Accumulating patterns of lipiodol and therapeutic effect of combination therapy with ADMOS and CDDP two-route infusion in hepatocellular carcinoma].
    Hiraki Y; Kobayashi H; Itoh Y; Yano T; Ikeda K; Sonoda T; Shinohara S
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2525-30. PubMed ID: 2843117
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intrahepatic arterial injections of cisplatin-phosphatidylcholine-Lipiodol suspension in two unresectable hepatoblastoma cases.
    Sue K; Ikeda K; Nakagawara A; Hironaga Y; Hachitanda Y; Otubo K; Mitsuishi T; Aoyama T
    Med Pediatr Oncol; 1989; 17(6):496-500. PubMed ID: 2555659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.